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Airborne fine particle mass concentrations (PM2.5) are used for ambient air quality management worldwide based in
part on known cardiorespiratory health effects. While oxidative stress is generally thought to be an important
mechanism in determining these effects, relatively few studies have specifically examined how oxidant defence
may impact susceptibility to particulate air pollution. Here we review studies that explore the impact of polymorphisms
in anti-oxidant related genes or anti-oxidant supplementation on PM2.5-induced cardiorespiratory outcomes in an effort
to summarize existing evidence related to oxidative stress defence and the health effects of PM2.5. Recent studies of
PM-oxidative burden were also examined. In total, nine studies were identified and reviewed and existing evidence
generally suggests that oxidant defence may modify the impact of PM2.5 exposure on various health outcomes,
particularly heart rate variability (a measure of autonomic function) which was the most common outcome examined
in the studies reviewed. Few studies examined interactions between PM2.5 and oxidant defence for respiratory
outcomes, and in general studies focused primarily on acute health effects. Therefore, further evaluation of the
potential modifying role of oxidant defence in PM2.5-induced health effects is required, particularly for chronic
outcomes. Similarly, while an exposure metric that captures the ability of PM2.5 to cause oxidative stress may offer
advantages over traditional mass concentration measurements, little epidemiological evidence is currently available to
evaluate the potential benefits of such an approach. Therefore, further evaluation is required to determine how this
metric may be incorporated in ambient air quality management.
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Airborne fine particle mass concentrations (PM2.5) are
used for ambient air quality management worldwide
based on years of epidemiological and toxicological evi-
dence suggesting adverse health effects [1,2]. Of the
plausible biological mechanisms explaining PM2.5 health
effects, oxidative stress is often cited as playing an im-
portant role in both respiratory and cardiovascular out-
comes [3-5]. For this reason, recent attention has focused
on PM oxidative burden as an approach to characterizing
particle toxicity [6-10] and some findings suggest high
spatial variability with proximity to traffic [7,9,10].
However, it is unclear as to how such measures may
be incorporated into regulatory air quality management
as relatively few studies have specifically examined the* Correspondence: Scott.Weichenthal@hc-sc.gc.ca
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distribution, and reproduction in any mediummodifying role of oxidant defence on PM2.5-induced car-
diorespiratory morbidity.
Here we review epidemiological evidence related to
the role of oxidative stress (and oxidant defence) in PM-
induced cardiorespiratory morbidity. In particular, we re-
view studies that explore potential effect modification by
polymorphisms in anti-oxidant genes or anti-oxidant
supplementation, as well as recent evidence examining
the association between PM-oxidative burden and ad-
verse health outcomes. In general, the goal of this review
paper was to examine heterogeneity in the magnitude
and direction of PM2.5 associations according to factors
that may impact oxidant defence and in doing so weigh
evidence for or against incorporating measures of PM2.5
oxidative burden in ambient air quality management.
Assays used to evaluate PM oxidative burden are not
discussed in detail; a thorough analysis of these methods
is available elsewhere [6].ntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Weichenthal et al. Environmental Health 2013, 12:40 Page 2 of 8
http://www.ehjournal.net/content/12/1/40Methods
Studies were identified through PubMed (http://www.
ncbi.nlm.nih.gov/pubmed/) using the operator AND in
combination with search terms including: air pollution/
fine particulate matter (PM2.5), oxidative stress, oxidative
stress genes/polymorphisms, dietary antioxidants, effect
modification, respiratory health, and cardiovascular health.
For example, typical search terms included: 1) PM2.5, oxi-
dative stress, AND cardiovascular health; 2) PM2.5, oxida-
tive stress, AND respiratory health; 3) PM2.5, oxidative
potential, AND effect modification; 4) Similar combina-
tions using the terms above. Abstracts of articles retrieved
were examined and studies were only included if they
were published in English before July 4, 2012 and specific-
ally examined he role of oxidative stress/oxidative stress
defence in PM2.5-induced cardiorespiratory health effects
in humans and/or specifically examined the health effects
of PM-oxidative potential.
Citation lists from these articles were also examined.
In total, nine studies were identified that met the above
criteria and all of these studies were included in the re-
view (Table 1).
In particular, studies listed in Table 1 include 4 new
studies [11-15] as well five studies [16-20] previously dis-
cussed by Zanobetti et al. [21].Results
Polymorphisms in anti-oxidant related genes
Cardiovascular health effects
Reactive oxygen species (ROS) are produced in the body
both through natural biological processes as well as in
response to external stimuli such as air pollution [3,5].
As such, mechanisms have evolved to maintain cellular
redox equilibrium to counter the potential adverse health
effects of oxidative stress including damage to cellular
macromolecules (e.g. proteins, DNA, membranes), inflam-
mation, and cytotoxicity [3,5]. A number of anti-oxidant
related genes have been identified and several studies have
examined the degree to which polymorphisms in these
genes may modify responses to PM with an aerodynamic
diameter less than 2.5 μm (PM2.5) (Table 1).
Zanobetti et al. [21] recently reviewed a number of
studies examining gene-air pollution interactions with
respect to cardiovascular morbidity. Of the sixteen stud-
ies reviewed, five studies specifically examined the effects
of PM2.5 exposure according to gene polymorphisms re-
lated to anti-oxidant defence [16-20]. However, all five of
these studies were conducted in the same population
of elderly Caucasian men (The Normative Aging
Study) [22]. Polymorphisms in genes coding for gluta-
thione S-transferase enzymes (GSTM1, GSTP1, GSTT1)
were examined most often but variants in genes for heme
oxygenase-1 (HMOX-1), hemocromatosis (HFE), NAD(P)H dehydrogenase [quinine] 1 (NQO1), and catalase (CAT)
were also examined.
The GST family of enzymes play a crucial role in anti-
oxidant defence as they catalyze the conjunction of ROS
with reduced glutathione (GSH), thereby neutralizing the
source of oxidative stress [23,24]. Polymorphisms in GST
genes are common, and studies reviewed by Zanobetti
et al. [21] suggest that these polymorphisms may impact
susceptibility to PM2.5-induced changes in autonomic con-
trol of the heart. Specifically, elderly male subjects with
the GSTM1-null genotype (i.e. non-functional genotype)
displayed decreased high-frequency heart rate variability
(HRV) with increased ambient PM2.5 but this association
was not observed among subjects with the functional al-
lele [16]. Interestingly, this study also reported that statin
use (a lipid lowering drug with anti-oxidant activity)
among GSTM1-null subjects eliminated the association
between PM2.5 and HRV. In an extended follow-up of the
same population, Chahine et al. [18] reported similar find-
ings with respect to GSTM1, HRV, and PM2.5 and also
reported that polymorphisms in the HMOX-1 promoter
modified the effect of PM2.5 on HRV. However, tests for
interaction between PM2.5 and gene polymorphisms were
not statistically significant for GSTM1 (0.12 ≤ p ≤ 0.15) or
HMOX-1 (0.06 ≤ p ≤ 0.11). HMOX-1 is an inducible en-
zyme that is produced as part of cellular oxidative stress
defence [25], and Chahine et al. [18] reported that ambient
PM2.5 was inversely associated with HRV among subjects
with a high number of GT repeats in the HMOX-1 pro-
moter region (a gene variant known to decrease HMOX-1
expression) but not among subjects with short repeats. In
addition, statistically significant (0.008 ≤ p ≤ 0.04) three-
way interactions were reported between PM2.5, HMOX-1,
and GSTM1 with the strongest inverse associations be-
tween PM2.5 and HRV observed among subjects who
had both the GSTM1 null genotype and long GT re-
peats in the HMOX-1 promoter. In a more recent study,
Madrigano et al. [19] examined the potential impact of
anti-oxidant gene polymorphisms (GSTM1, HMOX-1,
HFE) on the relationship between PM2.5 and serum con-
centrations of soluble adhesion molecules involved in
endothelial dysfunction (soluble intercellular adhesion
molecule, sICAM-1; soluble vascular cell adhesion mol-
ecule, sVCAM-1). Ambient PM2.5 concentrations were
not associated with changes in sICAM-1 or sVCAM-1
and evidence of effect modification was not observed for
these outcomes (interaction p-value not reported).
Park et al. [17] also examined gene-environmental in-
teractions with respect to ambient PM2.5 and HRV but fo-
cused on polymorphisms in the HFE gene. The protein
product of the HFE gene participates in iron uptake into
cells, thereby reducing its ability to participate in Fenton
reactions that generate reactive oxygen species [3,26]. Two
functional polymorphisms in the HFE gene are known to
Table 1 Studies of genetic polymorphisms, anti-oxidant supplements, and PM2.5-induced cardiorespiratory morbidity
Study Design and location Population Polymorphism(s)/
treatment










GSTM1 48-hour average PM2.5 HF Change Per 10 μg/m3 GSTM1-present − 3.6% (95% CI: -40.5, 56.2)











48-hour average PM2.5 SDNN, HF, LF Change per 10 μg/m
3 GSTM1-present SDNN: -2.0% (95% CI: -11.3, 8.3) HF:
-4.0% (95% CI: -24.8, 22.6) LF:-0.6% (95% CI: -19.0, 22.0) GSTM1-null SDNN:
-10.5% (95% CI: -18.2, -2.2) HF: -24.2% (95% CI: -39.2, -5.5) LF: -17.0% (95% CI:
-31.0, -0.2) HMOX-1 short repeat SDNN: 7.4% (95% CI:-8.7, 26.2) HF: 8.9%
(95% CI:-27.1, 62.8) LF: 14.0% (95% CI: -18.6, 59.5) HMOX-1 long repeat SDNN:
-8.5% (95% CI: -14.8, -1.8) HF: -20.1% (95% CI: -32.9, -5.0) LF: -14.0% (95% CI:
-25.7, -0.5) GSTM1-null and HMOX-1 long repeat SDNN: -12.7% (95% CI: -20.6,









HFE 48-hour average PM2.5 HF LF LF/HF SDNN Change Per 10 μg/m3 HFE wild type HF: -31.7% (95% CI: -48.1, -10) The authors
noted that similar associations were observed for SDNN, LF, and LF/HF but the
















Change Per 4.56 μg/m3 HFE wild type 1.81% (95% CI: 0.46, 3.16) HFE-variant
(rs1800562)− 2.5% (95% CI: -5.68, 0.68) CAT wild type 0.75% (95% CI: -0.85, 2.35)









GSTM1 HMOX-1 HFE 1-3 day PM2.5
moving average
sICAM-1 sVCAM-1 Polymorphisms in GSTM1, HMOX-1, or HFE genes did not modify
the relationship between PM2.5 exposure and serum concentrations







2 g/day fish oil or
2 g/day soy oil
Daily Indoor PM2.5 HF LF pNN50
SDNN rMSSD
Change Per 8 μg/m3 Pre-Supplementation Group (fish oil) Log10 HF: -54%
(95% CI: -72, -24) Log10 LF: -48% (95% CI :-69, -15) Log10 pNN50: -44%
(95% CI : -56, -27) Log10 SDNN : -27% (95% CI : -37, -16) Log10 rMSSD:
-32% (95% CI: -43, -19) Supplementation Phase (fish oil) Log10 HF: -7% (95% CI:
-20, 7) Log10 LF: -10% (95% CI : -22, 3) Log10 pNN50: -5% (95% CI: -12, 2)











GSS Yearly Average PM2.5 Lung function
growth in: FEV1
FVC MMEF
Per 22.2 μg/m3 GSS-H0100000 FEV1: -124 ml (95% CI: -203, -45.3) FVC:
-92.9 ml (95% CI: -186, 0.2) MMEF: -193.9 ml/s (95% CI: -352.2, -35.6) Other
GSS Haplotypes FEV1: -49 ml (95% CI: -182, 83.9) FVC: -106.8 ml (95% CI:
-247, 33.2) MMEF: -70.9 ml/s (95% CI: -309, 167.3)
a Adjusted for age, smoking, body mass index, diastolic blood pressure, fasting blood glucose, alcohol consumption, cardiovascular medications, season, and temperature.
b Adjusted for age, smoking, body mass index, mean arterial blood pressure, high-density lipoprotein cholesterol, history of ischemic heart disease, fasting blood glucose, alcohol consumption, cardiovascular
medications, season, day of the week, and temperature.
c Adjusted for age, body mass index, systolic blood pressure, smoking, alcohol consumption, serum creatinine, plasma folate, and vitamins B6 and B12.
d Adjusted for age, temperature, obesity, smoking, statin use, and diabetes.
e Adjusted for age, sex, heart rate, hypertension, body mass index, and time of day.
f Adjusted for height, sex, body mass index, asthma diagnosis, respiratory illness at testing, exercise, smoking, ethnicity, cohort, town, field technician, GSTM1, and ancestry.
g HF, high frequency heart rate variability; LF, low frequency heart rate variability; SDNN, standard deviation of normal to normal intervals; pNN50, percentage of normal RR intervals differing by more than 50 ms;
rMSSD, root mean square of the sum of square differences between adjacent intervals; ICAM-1, soluble intercellular adhesion molecule; sVCAM-1, soluble vascular cell adhesion molecule; NQO1, NAD(P)H
dehydrogenase [quinine] 1; CAT, catalase; GSH, reduced glutathione; GSS, GSH synthetase; FEV1, forced expiratory volume in 1-second; FVC, forced vital capacity; MMEF, maximal mid-expiratory flow.
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bient PM2.5 was inversely associated with high-frequency
HRV among subjects with the wild type HFE gene but not
among those with either of the two gene variants (inter-
action p-value = 0.02). Moreover, Ren et al. [20] reported
that HFE gene variants also modified the association be-
tween ambient PM2.5 and total plasma homocysteine
levels with a positive association observed among carries
of the wild-type HFE gene and an inverse non-statistically
significant association observed for carriers of the variant
gene (interaction p-value < 0.05). Total plasma homocyst-
eine levels are a maker of systemic oxidative stress [27]
and are independent predictors of cardiovascular morbid-
ity [28,29]. In addition, Ren et al. [20] also reported evi-
dence of effect modification for a polymorphism in the
catalase (CAT-rs2300181) gene whereby PM2.5 was posi-
tively associated with plasma homocysteine in carriers of
the variant gene but not in carriers of the wild-type gene
(interaction p-value < 0.05). Catalase is an anti-oxidant en-
zyme that converts hydrogen peroxide to water and oxy-
gen and polymorphisms in this gene are thought to
decrease gene transcription and thus decrease anti-
oxidant capacity [30].
Respiratory health effects
Minelli et al. [31] recently reviewed a number of studies
examining interactions between anti-oxidant genes and
air pollution exposures with respect to respiratory func-
tion and airway disease. However, of the seventeen stud-
ies reviewed, only three included measures of ambient
PM2.5 [32-34] and two of these studies [32,34] did not
examine the impact of PM2.5 exposure on respiratory ef-
fects according to genotype; instead, genotype was
treated as a covariate in the analysis. Specifically, Hong
et al. [32] examined the relationship between ambient
PM2.5 and lung function in a panel of Korean school
children and reported that a 1-day lag in PM2.5 levels
were associated with decreased daily mean peak expira-
tory flow rate (−0.54 L/min per 1 μg/m3, p < 0.01); ad-
justing for polymorphisms in GSTM1 or GSTT1 genes
(null versus present) did not substantially change this
association. Islam et al. [34] examined asthma incidence
among school children in southern California and
reported increased risk among carriers of the GSTM1-null
allele (Hazard Ratio (HR): 1.61, 95% CI: 1.2, 2.2) and de-
creased asthma risk among carriers of the Valine105 allele
for GSTT1 (HR: 0.60, 95% CI: 0.4, 0.8). A second poly-
morphism in the GSTT1 gene that decreases anti-oxidant
activity was also associated with increased asthma risk
(HR: 1.40, 95% CI: 1.1, 1.9); adjusting for ambient PM2.5
did not change effect estimates for gene variants but asso-
ciations for PM2.5 were not reported. Finally, the third
study did not present data for PM2.5 but only mentioned
that significant interactions were not observed betweennon-ozone pollutants (including PM2.5) and polymor-
phisms in the HMOX-1 gene with respect to asthma inci-
dence during adolescence [33].
One additional study was identified that examined gene-
environment interactions with respect to PM2.5 and re-
spiratory morbidity since the review by Minelli et al.
[31]. Specifically, Breton et al. [11] examined whether
polymorphisms in genes involved in glutathione (GSH)
synthesis modify the impact of PM2.5 exposure on lung
function growth in children (i.e. the increase in lung
function over time). In particular, a polymorphism in
glutathione synthetase (GSS) (the enzyme that catalyses
the production of reduced glutathione required to re-
spond to oxidative stress) was independently associated
with decreased lung function growth among children. In
addition, PM2.5 exposure was associated with greater de-
creases in lung function growth among children with the
GSS-H0100000 variant than those with other variants
(Table 1); however, tests for interaction were not statisti-
cally significant (0.44 ≤ p ≤ 0.70).
Anti-oxidant supplementation
Few studies have specifically examined the impact of
anti-oxidant supplementation on the cardiorespiratory
effects of PM2.5 exposure. Romieu et al. [12] examined
the impact of omega-3 polyunsaturated fatty acid sup-
plementation on the relationship between indoor PM2.5
and HRV among elderly nursing home residents in
Mexico City. In this study, subjects were randomized to
receive treatment with either fish oil (2 g/day) or soy oil
(2 g/day) and were followed for six months (1-month
before supplementation and 5-months after). Prior to
supplementation, a 1-standard deviation change in in-
door PM2.5 (8 μg/m
3) was associated with statistically
significant decreases in time and frequency domain
measures of HRV in both groups. After supplementa-
tion, both supplements blunted the effect of same-day
indoor PM2.5 on HRV but this effect was greatest for
fish oil which contained a higher concentration of
omega-3 fatty acids (Table 1). Tong et al. [13] re-
ported similar findings with respect to fish oil supple-
mentation and HRV among elderly adults in a more
recent study of controlled exposure to concentrated
ambient particles but they did not present findings
for PM2.5 specifically.
PM oxidative stress potential
Studies examining the potential health effects of ambient
PM2.5 oxidative burden were not identified, but two re-
cent studies examined the health impacts of ambient
PM10 oxidative burden (Table 2). Specifically, Tonne et al.
[14] examined the relationship between ambient PM10
oxidative burden and carotid intima-media thickness, a
measure of subclinical atherosclerosis. Most participants
Table 2 Studies of PM oxidative potential and cardiorespiratory morbidity









Predicted weekly average PM10
and PM10 Oxidative Potential
(PM10*OP) at the center of
each participants’ postal code





Change Per 1.5/m3 PM10*OP 1.2%









5-hour exposure to PM10 oxidative
potential at five different locations
FENO FVC Effect estimates for FENO ranged
from −0.45% to 0.11% per 38.71
change in PM10*OP depending on the
co-pollutant included in the model
Effect estimate for FVC ranged
from −0.01% to 0.05% per 38.71
change in PM10*OP depending
on the co-pollutant included
in the model
a Adjusted for age, sex, smoking, BMI, season, and year. b Adjusted for temperature, relative humidity, season, pollen counts, respiratory infection, and co-pollutants.
c FENO, Exhaled NO; FVC, forced vital capacity.
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den were estimated at the center of each participant’s
postal code using geostatistical models. The primary ex-
posure variable was PM10 weighted by oxidative burden
averaged during the 52 weeks prior to assessment of
intima-media thickness. This study measured PM oxida-
tive burden as the ability of PM extracts to deplete anti-
oxidants from a simulated respiratory tract lining fluid
model (RTLF). This chemical model included a compos-
ite solution of the three major water soluble antioxidants
(glutathione, urate, and ascorbate) at physiological con-
centrations which serve as the first line of protective de-
fence in the airway against the oxidative activity of PM
[35]. This assay measures the intrinsic oxidative poten-
tial of PM and does not capture oxidative stress caused
by cellular activation; therefore, it underestimates the
total oxidative burden of PM. In this study, an interquar-
tile change in PM10 weighted by oxidative burden was
associated with a 1.2% (95% CI: 0.2, 2.2) increase in
intima-media thickness; however, a stronger relationship
was observed for PM10 mass concentration measure-
ments (5% increase, 95% CI: 1.9, 8.3).
Strak et al. [15] used the same assay to evaluate the
acute respiratory health effects of PM10 oxidative burden
in a panel of healthy adult volunteers. Subjects were ex-
posed to ambient air pollution at five different locations
including two traffic sites, an urban background loca-
tion, an underground train station, and a farm, and de-
tailed air pollution measurements were collected during
5-hour exposures at each site. In this study, PM2.5,
PM10, and PM10 oxidative burden (measured as the abil-
ity of filter extracts to deplete reduced glutathione and
ascorbate) did not have an important impact on acute
changes in exhaled NO or lung function; however, sig-
nificant relationships were reported for ultrafine parti-
cles and NO2/NOx.Discussion
In total, seven studies were identified that specifically ex-
amined the impact of polymorphisms in anti-oxidant
genes or anti-oxidant supplementation on PM2.5 induced
cardiorespiratory morbidity. Two additional studies were
identified that examined the impact of PM10 oxidative
burden on cardiorespiratory morbidity; however, studies
of PM2.5 oxidative burden were not identified. In gen-
eral, studies to date have primarily examined the impact
of polymorphisms in anti-oxidant genes, anti-oxidant
supplementation, or PM oxidative potential on the acute
cardiorespiratory health effects of PM2.5 exposure
(48 hours to 7 days) with only one study [11] examining
effect modification over longer time-periods.
Of the six studies that examined the impact of anti-
oxidant gene polymorphisms on PM2.5 induced cardiore-
spiratory morbidity, three examined heart rate variability
as the primary outcome, one examined serum concen-
trations of soluble adhesion molecules involved in endo-
thelial dysfunction, and one examined total plasma
homocysteine. In general, stronger inverse associations
were observed between PM2.5 and HRV among subjects
with genetic polymorphisms that impaired oxidant de-
fence; however, all of these studies were conducted in
the same population of elderly Caucasian men and it is
not clear if these findings are generalizable to other pop-
ulations. Nevertheless, a recent meta-analysis generally
supports an inverse relationship between PM2.5 and
HRV suggesting worse cardiovascular prognosis with in-
creased exposure [36]. It is difficult to gage the
consistency of other findings as evidence is limited to
single studies for the remaining outcomes. Nevertheless,
findings from a double-blind trial of dietary anti-oxidant
supplementation support the role of oxidative stress in
PM2.5-induced changes in HRV as anti-oxidant supple-
mentation was found to reduce inverse associations
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measures of HRV [12]. In addition, a polymorphism in
the enzyme needed to produce reduced glutathione (im-
portant for oxidant defence) was found to modify the
impact of PM2.5 exposure on lung function growth
among children, although tests for interaction were not
statistically significant [11]. Therefore, although the
number of studies is limited, existing evidence is consist-
ent with a potential modifying role of oxidant defence in
PM2.5 induced cardiorespiratory morbidity. As a result,
an exposure measure that captures the ability of PM2.5
to cause oxidative stress may offer advantages over trad-
itional mass concentration measurements. However, as
outlined below, sufficient evidence is not yet available to
determine the precise form that such a metric may take.
Conceptually, PM oxidative burden is an appealing ex-
posure metric for epidemiological analysis as it aims to
capture the ability of PM to modify a biological process
known to contribute to adverse cardiorespiratory health
effects. However, identifying the most important predic-
tors of this measure may not be a straightforward
process as some authors have reported heterogeneous
associations between PM2.5 components and oxidative
capacity [37]. While the studies reviewed suggest that
oxidant defence may impact susceptibility to PM-
induced cardiorespiratory morbidity, few epidemiological
studies have specifically examined PM oxidative burden.
As a result, little evidence is available to gauge the po-
tential role of this metric in ambient air quality manage-
ment. Specifically, studies of PM2.5 oxidative burden
were not identified and only two studies examined the
association between PM10 oxidative burden and cardio-
respiratory morbidity; neither reported strong associa-
tions. However, the first of these studies [14] relied on
statistical models to estimate PM10 oxidative burden and
the authors reported that the performance of this model
was lower (R2 = 0.47) than the model for PM10 (R
2 =
0.83) in cross validation studies. Therefore, increased ex-
posure measurement error may have attenuated effect
estimates for the association between PM10 oxidative
burden and carotid intima-media thickness to a larger
extent than those for PM10 mass concentration. Never-
theless, the second study monitored PM10 oxidative po-
tential exposures directly but did not observe a
meaningful association between this measure and acute
changes in exhaled NO or lung function in healthy
adults [15]. As a number of methods are available to
evaluate PM oxidative burden [6], one explanation for
the null findings above may be that the particular assay
used did not adequately reflect the true “biological” oxi-
dative potential of the particles monitored. Indeed, the
method employed in these studies relies on an acellular
assay of simulated respiratory tract lining fluid con-
taining antioxidants known to be present in the lung:glutathione and ascorbate [6]. As the authors acknow-
ledge, this assay does not reflect total oxidative burden
which requires cell/tissue interactions with particles,
only the inherent ability of particles to deplete antioxi-
dants present in the respiratory tract lining fluid. Never-
theless, oxidative potential measures from this assay
have been shown to vary with proximity to important
sources of air pollution such as traffic [9,10] and further
evaluation of an expanded set of health outcomes with
both acute and chronic exposure intervals are required
before the validity of this measure can be fairly assessed.
Likewise, other measures of PM oxidative burden should
also be explored in future epidemiological analysis of air
pollution health effects in order to identify those that
most reliably predict integrated particle toxicity and con-
sider multiple determinants (e.g. transition metals, poly-
cyclic aromatic hydrocarbons) of oxidant capacity.
Indeed, if identified such measures may offer additional
methods of communicating regional differences in air
quality and potentially move us beyond the assumption
that PM mass concentrations pose equal health risks re-
gardless of sources and/or composition in a given area.
Conclusions
In general, existing evidence suggests that altered oxi-
dant defence may have a meaningful impact on PM2.5
health effects, particularly for HRV (a measure of auto-
nomic function) which was the most common outcome
examined in the studies reviewed. Nevertheless, rela-
tively few studies have specifically examined the impact
of oxidant defence on associations between ambient
PM2.5 and cardiorespiratory morbidity and little is
known about the association between PM-oxidative po-
tential and adverse health outcomes. In addition, evi-
dence to date is largely limited to a population of elderly
Caucasian men and further evaluation of effect modifica-
tion by polymorphisms in anti-oxidant genes or dietary
anti-oxidants is warranted as these factors may play an
important role in determining population susceptibilities
to PM-induced health effects. Moving forward, further
effort is required in evaluating how PM-oxidative burden
may be incorporated in ambient air quality management.
This will include evaluation of multiple metrics as well
as their use in epidemiological studies of both the
chronic and acute health effects of particulate air pollu-
tion. If identified, a reliable and valid measure of inte-
grated particle toxicity would offer an additional means
of communicating regional differences in air quality and
may allow regulators to directly target specific determi-
nants of particle toxicity.
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